Deka Biosciences, Inc., is an early-stage biotechnology company focused on generating the next generation targeted cytokine therapies to treat cancer and inflammatory diseases. Deka is developing the dual cytokine, (DiakineTM) platform. Diakines are comprised of optimized, stimulatory, or suppressive disease specific IL-10 variants coupled to other stimulatory or suppressive cytokines via a T1/2 life extending tissue targeting, non-immunogenic scFv technology.
Deka BioSciences Address
20378 Seneca Meadows Pkwy Rockville, null
Deka BioSciences Email
Past Companies
Deka Biosciences, IncAssociate Director, Program Management
SirnaomicsSenior Project Manager
Frederick National Lab for Cancer Research ,(Leidos Biomedical Research, Inc)Scientific Project Manager,NExT CBC Support Programs (NCI)